genXone S.A. (WSE:GX1)

Market Cap	19.17M
Revenue (ttm)	1.79M
Net Income (ttm)	-3.94M
Shares Out	3.30M
EPS (ttm)	-1.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	487
Average Volume	4,097
Open	6.00
Previous Close	6.00
Day's Range	5.76 - 6.04
52-Week Range	4.85 - 8.48
Beta	-0.83
RSI	38.84
Earnings Date	Feb 10, 2025

About genXone

genXone S.A. operates in the biotechnology industry in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It offers nucleic acid sequencing services based on nanopore sequencing technology. The company develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. is ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• CEO: Michal Kaszuba
• Employees: 20
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GX1

Financial Performance

In 2024, genXone's revenue was 1.79 million, a decrease of -25.33% compared to the previous year's 2.39 million. Losses were -3.94 million, 5.87% more than in 2023.